• contact@coremarketresearch.com
Explore the global Peripheral IV Catheters with in-depth analysis

Peripheral IV Catheters Market Segments - by Product Type (Short Peripheral IV Catheters, Integrated/Closed Peripheral IV Catheters, Ported Peripheral IV Catheters, Non-ported Peripheral IV Catheters, Winged Steel Needles), Application (Hospitals, Clinics, Ambulatory Surgical Centers, Homecare Settings, Others), Distribution Channel (Hospitals Pharmacies, Retail Pharmacies, Online Sales), Material Type (Polyurethane, Silicone, Teflon, Others), and Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2025-2035

Peripheral IV Catheters Market Outlook

The global peripheral IV catheters market is projected to reach USD 6.5 billion by 2035, growing at a CAGR of approximately 6.5% from 2025 to 2035. The rising prevalence of chronic diseases such as diabetes and cardiovascular conditions, along with the increasing number of surgical procedures, is driving the demand for peripheral IV catheters. Additionally, advancements in catheter technology, such as the development of integrated systems that minimize the risk of complications, are contributing to market growth. The growing emphasis on patient safety and infection control measures further enhances the demand for peripheral IV catheters, as healthcare providers seek to minimize the risks associated with intravenous therapy. As healthcare systems evolve and prioritize efficient patient care, the role of peripheral IV catheters becomes increasingly significant.

Growth Factor of the Market

The growth of the peripheral IV catheters market is largely fueled by the increasing incidence of hospital admissions due to chronic and acute medical conditions that necessitate intravenous treatment. Moreover, the elderly population is rapidly growing, leading to higher healthcare needs and enhanced utilization of peripheral IV catheters for treatments. The ongoing technological advancements in medical devices, including the introduction of catheters equipped with safety features and enhanced biocompatibility, are also pivotal growth factors. Furthermore, the rising awareness among healthcare professionals regarding the importance of infection prevention in intravenous therapy has led to greater demand for advanced peripheral IV catheter systems. The expansion of healthcare infrastructure and investments in medical technology also play critical roles in propelling the market forward, as they facilitate wider access to innovative healthcare solutions.

Key Highlights of the Market
  • The global peripheral IV catheters market is expected to witness a CAGR of 6.5% from 2025 to 2035.
  • Technological advancements, such as safety-engineered devices, are becoming mainstream.
  • The increasing prevalence of chronic diseases is driving demand for IV therapy solutions.
  • North America currently holds the largest market share due to advanced healthcare infrastructure.
  • A growing focus on infection control measures is influencing market dynamics significantly.

By Product Type

Short Peripheral IV Catheters:

Short peripheral IV catheters are widely used in various healthcare settings for the rapid administration of medications and fluids. These catheters are typically inserted into a peripheral vein, allowing for easy access to the vascular system. Their popularity can be attributed to their versatility in administering a wide range of drugs, including chemotherapy, antibiotics, and analgesics. The short-term use of these catheters makes them ideal for patients who require brief infusions or venous access, such as those undergoing outpatient procedures. Additionally, advancements in catheter technology have led to the development of materials that reduce the risk of phlebitis and infiltration, thereby enhancing patient safety and comfort. The demand for short peripheral IV catheters continues to grow in tandem with an increasing number of inpatient and outpatient treatments.

Integrated/Closed Peripheral IV Catheters:

Integrated or closed peripheral IV catheters are designed to minimize the risk of contamination and complications associated with IV therapy. These systems incorporate features such as needleless connectors and closed systems that prevent air entry into the catheter. The growing emphasis on patient safety and infection control has significantly boosted the demand for integrated catheters, particularly in hospital settings where patients are at higher risk for infections. Furthermore, these catheters facilitate easier and safer blood sampling, which is essential for many diagnostic procedures. The market for integrated peripheral IV catheters is expected to expand as healthcare providers increasingly adopt advanced technologies to improve patient outcomes and streamline IV administration processes.

Ported Peripheral IV Catheters:

Ported peripheral IV catheters are designed with an additional port that allows for multiple infusions or blood sampling without the need for multiple punctures. This design not only enhances patient comfort but also minimizes the risk of complications associated with repeated venipuncture. The growing preference for less invasive procedures among healthcare professionals has contributed to the increased adoption of ported catheters, particularly in settings that require frequent medication administration. Moreover, their utility in pediatric and geriatric populations, who may have challenging venous access, further drives the market for ported peripheral IV catheters. As hospitals and clinics continue to seek efficient and effective solutions for intravenous therapy, the ported catheter segment is expected to witness significant growth.

Non-ported Peripheral IV Catheters:

Non-ported peripheral IV catheters are traditional devices used for direct venous access, and they remain widely utilized due to their simplicity and effectiveness. These catheters are often cost-effective and straightforward to use, making them a preferred choice in various healthcare settings. Despite the rise of advanced catheter systems, non-ported catheters continue to hold a significant share of the market, particularly in emergency departments and settings that require rapid venous access. While they may not offer the same infection control features as integrated systems, their reliability and ease of use keep them in demand. The non-ported peripheral IV catheter segment is expected to maintain its relevance in the market, especially for short-term intravenous therapy.

Winged Steel Needles:

Winged steel needles, also known as butterfly needles, are a specialized type of peripheral IV catheter that is particularly effective for venipuncture in small veins and pediatrics. These needles are equipped with flexible "wings" that provide better control during insertion, making them ideal for situations where precision is crucial. The demand for winged steel needles is bolstered by their applicability in diagnostic testing and short-term therapies, as well as their convenience in outpatient settings. As healthcare providers continue to prioritize patient comfort and safety, the market for winged steel needles is expected to grow steadily, especially in areas where less invasive options are favored.

By Application

Hospitals:

Hospitals constitute the largest segment in the application of peripheral IV catheters, primarily due to the high volume of inpatient treatments that require intravenous administration. The wide range of medical services offered in hospitals, including emergency care, surgery, and oncology, necessitates the use of IV catheters for medication delivery, hydration, and blood transfusions. Furthermore, hospitals are increasingly adopting advanced catheter technologies to reduce the risk of complications such as infections and phlebitis, thereby enhancing patient safety. The growing number of surgical procedures and the rising prevalence of chronic diseases continue to drive the demand for peripheral IV catheters in hospital settings, positioning this segment as a critical contributor to market growth.

Clinics:

Clinics are increasingly adopting peripheral IV catheters for outpatient treatments that require medication and fluid administration. This trend is driven by the rising demand for minimally invasive procedures and the growing emphasis on outpatient care. The ability to provide efficient IV therapy in a clinic setting is particularly beneficial for patients who require regular treatments, such as chemotherapy or infusions for chronic conditions. As clinics enhance their service offerings to include advanced therapeutic options, the utilization of peripheral IV catheters is expected to rise significantly. The convenience of clinic-based IV therapy allows for better patient management and reduces the burden on hospital resources, thereby supporting the growth of this segment.

Ambulatory Surgical Centers:

Ambulatory Surgical Centers (ASCs) are seeing an increased use of peripheral IV catheters as they serve as hubs for outpatient surgical procedures that require anesthesia and postoperative care. The preference for outpatient surgeries is rising, driven by patient desires for convenience and cost-effectiveness. Peripheral IV catheters are critical for administering anesthesia, fluids, and medications during surgeries performed in ASCs, enabling efficient patient care and quick recovery times. As more surgical procedures move from traditional hospital settings to ASCs, the demand for peripheral IV catheters in these facilities will continue to grow, further solidifying their importance in the overall healthcare landscape.

Homecare Settings:

The demand for peripheral IV catheters in homecare settings is on the rise, driven by an increasing focus on patient-centric care and the growing number of patients receiving treatments at home. Home healthcare allows patients to receive necessary intravenous therapies, such as antibiotics or hydration, without the need for hospitalization. This approach enhances patient comfort and independence while reducing healthcare costs associated with prolonged hospital stays. Peripheral IV catheters enable healthcare professionals to provide effective and safe IV therapy in home settings, which is particularly advantageous for patients with chronic diseases requiring ongoing treatment. The homecare segment is expected to witness significant growth as healthcare systems adapt to changing patient needs and preferences.

Others:

Beyond hospitals, clinics, ambulatory surgical centers, and homecare settings, there are other applications for peripheral IV catheters, including veterinary medicine and specialized care facilities. In veterinary practice, IV catheters are used for administering medications and fluids to animals, significantly improving the quality of care provided. Additionally, specialized facilities such as rehabilitation centers and palliative care units also utilize peripheral IV catheters for patient management. The diversification of applications across various healthcare sectors presents new opportunities for market growth, as innovative catheter solutions can enhance care quality and efficiency in these environments.

By Distribution Channel

Hospitals Pharmacies:

Hospital pharmacies play a crucial role in the distribution of peripheral IV catheters within healthcare facilities. These pharmacies are responsible for managing the inventory of medical devices, ensuring that clinicians have access to the necessary supplies for patient care. With the increasing demand for IV therapies, hospital pharmacies are focusing on maintaining a diverse range of catheter options, including specialized designs that enhance safety and efficacy. Furthermore, partnerships between catheter manufacturers and hospital pharmacies are becoming more common, enabling streamlined procurement processes and improved supply chain management. The presence of hospital pharmacies as a primary distribution channel will continue to influence the availability and accessibility of peripheral IV catheters in hospitals.

Retail Pharmacies:

Retail pharmacies have emerged as significant distribution channels for peripheral IV catheters, particularly for homecare settings and outpatient treatments. As patients increasingly prefer to manage their healthcare needs independently, retail pharmacies are stepping up to meet the demand for IV catheters and associated supplies. The convenience of purchasing medical devices at local pharmacies increases accessibility for patients who require home IV therapy or outpatient care. Additionally, retail pharmacies often provide guidance and support to patients regarding the use of these devices, enhancing patient education and compliance. The growth of retail pharmacies as distribution channels will contribute to the overall expansion of the peripheral IV catheters market.

Online Sales:

Online sales channels for peripheral IV catheters have gained traction as more healthcare providers and patients seek convenient purchasing options. The rise of e-commerce has transformed the way medical supplies are bought and sold, allowing for easier access to a wide range of catheter products. Online platforms often provide comprehensive product information, customer reviews, and competitive pricing, attracting a growing number of consumers. Furthermore, the increasing trend of telehealth services has accelerated the adoption of online sales, as healthcare professionals and patients look for efficient ways to procure necessary medical devices. The online sales segment is expected to continue growing, driven by technological advancements and changing consumer preferences.

By Material Type

Polyurethane:

Polyurethane is one of the most commonly used materials for manufacturing peripheral IV catheters due to its biocompatibility and flexibility. This material offers a combination of strength and pliability, making it ideal for various catheter designs that require durability while maintaining patient comfort. Polyurethane catheters are also less likely to cause phlebitis and other complications associated with prolonged use, which is essential in clinical settings where patients require extended intravenous therapy. The ongoing development of polyurethane formulations continues to enhance the performance of these catheters, making them a preferred choice among healthcare providers. The growing awareness of patient safety is further driving the demand for polyurethane-based peripheral IV catheters in the market.

Silicone:

Silicone is another popular material for peripheral IV catheters, particularly in long-term venous access applications. Known for its biocompatibility and flexibility, silicone catheters can remain in place for extended periods without causing irritation or damage to the vein. The inherent properties of silicone also contribute to reduced thrombogenicity, making these catheters ideal for patients requiring long-term treatments such as chemotherapy or hydration. The market for silicone peripheral IV catheters is anticipated to grow as healthcare providers increasingly recognize the benefits of this material in minimizing complications associated with intravenous therapy. Moreover, silicone's resistance to kinking and blockage encourages its use in various clinical settings.

Teflon:

Teflon catheters are characterized by their smooth surface, which facilitates ease of insertion and reduces the risk of thrombosis. This material's hydrophobic properties minimize the adherence of blood components, making Teflon catheters an excellent choice for short-term intravenous therapy. They are often utilized in emergency and surgical settings where rapid venous access is required. The adoption of Teflon catheters is expected to gain momentum due to their effectiveness in minimizing complications and their ease of use. As healthcare providers continue to prioritize patient safety and comfort, Teflon peripheral IV catheters remain a viable option in the market.

Others:

Other material types in the peripheral IV catheters market include various blends and composites designed to enhance specific performance characteristics. These may include materials that offer increased strength, flexibility, or biocompatibility compared to traditional materials. The ongoing research and development in catheter materials are focused on improving patient outcomes and reducing the risk of complications associated with intravenous therapy. As healthcare providers seek innovative solutions to enhance IV therapy, the market for peripheral IV catheters made from alternative materials is expected to expand, driven by technological advancements and evolving clinical needs.

By Region

The North America region dominates the peripheral IV catheters market due to the advanced healthcare infrastructure and high adoption rates of innovative medical technologies. With an estimated market share of around 40%, the region is characterized by its substantial investments in research and development, further propelling market growth. The rising prevalence of chronic diseases and an increasing number of surgical procedures necessitate the use of peripheral IV catheters in clinical settings. The market in North America is expected to grow at a CAGR of approximately 6.5% during the forecast period, thanks to the ongoing focus on improving patient safety and enhancing healthcare outcomes.

In Europe, the peripheral IV catheters market is anticipated to witness steady growth, driven by the increasing demand for minimally invasive procedures and the growing emphasis on infection control. The region is projected to hold approximately 30% of the global market share, with key countries such as Germany, France, and the UK leading the market. Factors such as advancing healthcare technologies, the rising geriatric population, and the expansion of outpatient services are expected to contribute to the market's growth. As European healthcare systems adapt to changing patient needs, the demand for peripheral IV catheters in various applications is likely to rise, further enhancing the market landscape.

Opportunities

The peripheral IV catheters market presents numerous opportunities for growth and innovation, particularly in the realm of technological advancements. The development of smart IV catheters equipped with sensors and monitoring capabilities represents a significant opportunity for manufacturers to differentiate their products and provide enhanced patient care. These devices can offer real-time data on infusion rates, pressure, and other critical parameters, enabling healthcare providers to respond promptly to any complications that may arise during intravenous therapy. As healthcare systems increasingly adopt digital health solutions, the integration of smart technology into peripheral IV catheters is set to revolutionize patient management and improve clinical outcomes.

Another promising opportunity lies in the growing focus on training and education for healthcare professionals regarding the proper use of IV catheters. As the complexity of catheter designs increases, there is a corresponding need for healthcare providers to possess the skills and knowledge necessary for optimal catheter placement and maintenance. Companies that invest in developing comprehensive training programs and resources can enhance their market presence while improving patient safety. Furthermore, collaborations between manufacturers, healthcare providers, and educational institutions can facilitate the dissemination of best practices, ultimately benefiting patients and healthcare systems alike.

Threats

Despite the promising prospects for the peripheral IV catheters market, several threats may hinder its growth. One significant challenge is the increasing scrutiny on healthcare costs and resource allocation. As hospitals and healthcare facilities strive to minimize expenses, there may be a tendency to opt for lower-cost alternatives, potentially compromising the quality and safety of IV catheters. This shift could limit market growth for premium catheter products and undermine the emphasis on patient safety. Additionally, as healthcare systems implement tighter regulations on medical devices, manufacturers may face increased compliance costs and complexities in obtaining approvals for new catheter technologies, which could further impact market dynamics.

Another notable threat is the risk of catheter-related infections and complications, which can adversely affect patient outcomes and lead to increased healthcare costs. The rising incidence of hospital-acquired infections has led to heightened awareness among healthcare providers regarding the importance of infection prevention. As a result, there is growing pressure on manufacturers to develop innovative catheter designs that incorporate safety features to minimize the risk of complications. Failure to address these concerns may pose a significant challenge to the market, as healthcare providers increasingly prioritize patient safety and infection control measures when selecting intravenous therapy solutions.

Competitor Outlook

  • BD (Becton, Dickinson and Company)
  • Terumo Corporation
  • Smiths Medical
  • Medtronic plc
  • Teleflex Incorporated
  • Vygon S.A.
  • Amecath
  • Catalent, Inc.
  • Fresenius Kabi AG
  • Neomed, Inc.
  • Moog Inc.
  • West Pharmaceutical Services, Inc.
  • iVexSol, Inc.
  • B. Braun Melsungen AG
  • Halyard Health, Inc.

The competitive landscape of the peripheral IV catheters market is characterized by the presence of several established companies as well as emerging players seeking to capture market share through innovation and improved product offerings. Major players such as BD and Terumo Corporation dominate the industry, leveraging their extensive product portfolios and research capabilities to introduce advanced catheter technologies. These companies are actively investing in R&D to develop smart IV catheters with integrated monitoring systems, thereby enhancing patient care while addressing safety concerns. Additionally, a strong focus on partnerships and acquisitions among leading manufacturers is expected to drive growth, as companies aim to expand their market presence and diversify their product offerings.

Another key player, Medtronic, offers a range of peripheral IV catheter products designed to meet various clinical needs. The company is committed to advancing patient safety and improving healthcare outcomes through the development of innovative medical technologies. Its strategic focus on integrating digital solutions into IV therapy aligns with the growing trend of digitization in healthcare. Similarly, Teleflex Incorporated is recognized for its commitment to quality and innovation, providing a diverse array of peripheral IV catheter systems that prioritize patient comfort and safety. The company actively engages in collaborations with healthcare providers to develop tailored solutions that address specific clinical requirements, further enhancing its competitive edge in the market.

Emerging companies such as iVexSol and Amecath are also making strides in the peripheral IV catheters market, focusing on niche segments and targeting unmet medical needs. These companies are leveraging advancements in materials science and catheter design to create innovative solutions that enhance patient safety and simplify procedures. As the market evolves and patient expectations shift, the competitive landscape will continue to transform, with established players and new entrants alike striving to develop cutting-edge technologies that improve the quality of intravenous therapy.

  • October, 2025
  • MD-59269
  • 100
  • |
  • 4.7
  • 99
Buy Report
  • $3500
  • $5000
  • $6500